Summit Global Investments’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Summit Global Investments's ACLS Position: Q2 2026 in Review
Summit Global Investments reduced its Axcelis (ACLS) stake by 8.3% in Q2 2026, selling an estimated $98.5K and leaving 7,334 shares worth $1.39M. The position accounts for 0.08% of the portfolio, ranked #141.
Summit Global Investments first reported a position in ACLS in Q1 2023 and has held it in 10 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Summit Global Investments held 7,334 shares of Axcelis worth $1.39M as of Q2 2026.
- Summit Global Investments sold 664 Axcelis shares in Q2 2026, an estimated $98.5K.
- Axcelis made up 0.08% of Summit Global Investments's portfolio in Q2 2026, its #141 holding.
- Summit Global Investments first reported a position in Axcelis in Q1 2023 and has held it in 10 quarters since.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.